Navigation Links
Accelitech to Open the First CyberKnife Cancer Center Within the City of Chicago
Date:2/22/2012

CHICAGO, Feb. 22, 2012  /PRNewswire/ -- Accelitech LLC, a leading developer of stereotactic radiosurgery and cancer treatment programs, is pleased to announce its newest CyberKnife cancer center, which will begin treating patients in Chicago in the summer of 2012. Developed through a partnership between Accelitech, physicians and Swedish Covenant Hospital, the new CyberKnife Cancer Institute of Chicago will provide state-of-the-art CyberKnife treatment to patients from Chicago and beyond. This will be the first CyberKnife center within the city limits and will feature the latest technology of its kind in the region.

Centrally located and conveniently accessible from both downtown and suburban locations, the new 10,000-square-foot facility, now under construction, will be located at 160 East Illinois, in the heart of Chicago. The center will open and the clinical team will begin evaluating patients for treatment beginning this spring.

"Our vision is to create the very best setting for patient care and provide the most advanced cancer treatment technology available in the market," says Adam Dickler, MD, the Medical Director for the new CyberKnife center. "More than 20 cancer care physicians have been trained to use the CyberKnife, providing new treatment options for their patients."

"With this and every project, our goal is to bring new technology to patients who need it most, so we're very excited to add our Chicago site to a rapidly growing network of Accelitech CyberKnife centers," says Kerwin Brandt, CEO of Accelitech. "With nine existing locations and many more under development, we believe we are the largest and fastest growing private developer of CyberKnife centers in the country."

About Accelitech LLC

Accelitech LLC is a leading developer of stereotactic radiosurgery and cancer treatment programs. Headquartered in Chicago, IL, Accelitech is a privately held company with extensive experience and resources in healthcare, law, finance, development, and clinical operations. Accelitech provides the funds, expertise and legal models to allow physicians and hospitals to bring new technology to market for the benefit of the patients they serve. Accelitech has sites and projects under development throughout the United States.

For additional information about Accelitech and its services, please visit accelitech.biz.

About CyberKnife Cancer Institute of Chicago by Swedish Covenant Hospital

CyberKnife is the first and only robotic radiosurgery system delivering customizable, non-surgical treatments for a broad range of tumors anywhere in the body. Only the CyberKnife system allows practitioners to non-invasively deliver high doses of radiation to tumors with extreme accuracy and intense precision, providing personalized and tailored treatments that help clinicians pursue the best clinical outcomes for patients' individual needs. The CyberKnife Cancer Institute of Chicago will open the summer of 2012 and is located at 160 East Illinois, off of Michigan Avenue in Chicago.  For more information about the center's opening, visit accelitech.biz.

Media Inquiries:
Stacey McClenathan
Stacey@beecommunications.com


'/>"/>
SOURCE Accelitech LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Research and Markets has announced the addition of the "Dry ... offering. ... Dry eye Drugs Price Analysis and Strategies - 2016, provides drug pricing ... answers the following questions: What are the ... they positioned in the Global Dry eye market? What ...
(Date:2/24/2017)... Feb. 23, 2017 The U.S. Food ... PhenoTest BC Kit, performed on the Pheno System. ... that cause bloodstream infections and provide information about ... to (antibiotic sensitivity). The test also reduces the ... important information, which can guide antibiotic treatment recommendations ...
(Date:2/24/2017)... 23, 2017  This report analyzes the worldwide markets ... Products: Intermediates, Analytical, and Others. The ... Pharmaceuticals, and Agrochemicals. The report provides separate comprehensive analytics ... Europe , and Rest of World. Annual ... through 2022. Also, a six-year historic analysis is provided ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... 24, 2017 , ... In the Health Care IT campaign, Robert Herjavec discusses ... not if you will be attacked, but when.” However, he and many others involved ... care. , Improvements in auditing and monitoring have taken security in health care a ...
(Date:2/24/2017)... ... February 24, 2017 , ... Healthcare Associates of McKinney ... Craig Ranch building at 8080 State Highway 121, Suite 210, McKinney, Texas 75070. ... to Highway 121. , As the practice has grown, the need for more space ...
(Date:2/24/2017)... ... February 24, 2017 , ... With ProGlass Prism users ... X . Users have total control over position, rotation, distortion, edge softness, edge blur, ... Final Cut Pro X. , With ProGlass Prism users are given the tools ...
(Date:2/24/2017)... Texas (PRWEB) , ... February 24, 2017 , ... Yisrayl ... that focuses on Bible Prophecy concerning this present generation. Yisrayl makes an astounding ... this current generation. He explains that the Bible details the current times so ...
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President and CEO Kelly ... Dyer started as the Chairman of the Management Committee when IFN was originally ... including the recruitment of investor/owners and development of the business plan. He became ...
Breaking Medicine News(10 mins):